Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial
Clinical Gastroenterology and Hepatology · 2026-04 · 24 (4) · 1092-1101
DOI: 10.1016/j.cgh.2025.08.005 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-04. Verfasst von Judith Wellens und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chronic Diseases and Metabolism, Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium; Dep…. Hauptthemen laut MEDLINE: Emulsifying Agents, Gastrointestinal Microbiome, Inflammation, Diet. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Universitaire Ziekenhuizen Leuven, KU Leuven.
Abstract (Originalsprache)
BACKGROUND & AIMS: Dietary emulsifier consumption might promote intestinal inflammation, eventually leading to inflammatory bowel diseases. However, human data are scarce and involve a limited number of emulsifiers. We studied the effects of an emulsifier-free diet (EFD) and specific emulsifier supplementation. METHODS: Sixty healthy participants followed an EFD for 2 weeks. Then, using a randomized placebo-controlled trial design, participants continued an EFD for 4 weeks with the addition of either carboxymethyl cellulose, polysorbate-80, carrageenan, soy lecithin, native rice starch, or no additives administered through brownies. Effects on cardiometabolic markers, gut microbiota, intestinal inflammation, and permeability were explored. RESULTS: After 2 weeks of an EFD, cholesterol levels decreased (P = .00006). Under emulsifier supplementation, alpha diversity remained stable, yet microbial composition was affected by treatment and visit. Compared with placebo, concentrations of all short chain fatty acids were lower in those consuming carboxymethyl cellulose, which was mirrored by other emulsifiers, although not all reached significance. No differences in fecal calprotectin, C-reactive protein, serum lipopolysaccharide-binding protein, cholesterol levels, or other metabolic markers were observed between placebo and emulsifiers at the end of the intervention. Serum inflammatory and cardiometabolic proteins remained unchanged. In individuals consuming carrageenan, transcellular intestinal permeability increased (P = .04) compared with baseline. CONCLUSIONS: In this double-blind placebo-controlled exploratory trial, emulsifier supplementation lowered short chain fatty acid concentration compared with placebo. Emulsifier supplementation did not impact intestinal or systemic inflammation or metabolic endpoints. Cholesterol levels decreased after 2 weeks of an EFD. These results point towards potential intestinal benefits of limiting dietary emulsifiers in the diet, requiring further investigation. CLINICALTRIALS: gov, Number: NCT06552156.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chronic Diseases and Metabolism, Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium; Department of Gastroenterology and Hepatology, University Hospitals Leuve…
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
- Department of Chronic Diseases and Metabolism, Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
- Laboratory of Molecular Bacteriology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium; VIB Center For Microbiology, Leuven, Belgium.
- Department of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium; Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.
Förderung
- Universitaire Ziekenhuizen Leuven, KU Leuven
Zitieren
APA
Wellens, J., Vanderstappen, J., Hoekx, S., Vissers, E., Luppens, M., Van Elst, L., Lenfant, M., Raes, J., Derrien, M., Verstockt, B., Ferrante, M., Verbeke, K., Matthys, C., Vermeire, S., & Sabino, J. (2026). Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial. Clinical Gastroenterology and Hepatology, 24(4), 1092-1101. https://doi.org/10.1016/j.cgh.2025.08.005
Vancouver
Wellens J, Vanderstappen J, Hoekx S, Vissers E, Luppens M, Van Elst L, et al. Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial. Clinical Gastroenterology and Hepatology. 2026;24(4):1092-1101. doi:10.1016/j.cgh.2025.08.005
BibTeX
@article{Wellens2026,
author = {Wellens, Judith and Vanderstappen, Julie and Hoekx, Sien and Vissers, Eva and Luppens, Martijn and Van Elst, Lies and Lenfant, Matthias and Raes, Jeroen and Derrien, Muriel and Verstockt, Bram and Ferrante, Marc and Verbeke, Kristin and Matthys, Christophe and Vermeire, Séverine and Sabino, João},
title = {Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {4},
pages = {1092--1101},
doi = {10.1016/j.cgh.2025.08.005}
}
EUVIMED